The endotoxin problem nobody in the peptide market talks about

When most people evaluate a research peptide vendor, they look at one number: HPLC purity. 98%. 99%. Sometimes “99%+.” That number has become the default trust signal for the entire category.

I spent a long time thinking the same way. Then I started learning what HPLC doesn’t catch, and it changed how I think about compound quality entirely.

HPLC measures the purity of the target compound relative to other UV-absorbing compounds in the sample. What it does not detect is endotoxin contamination.

Endotoxins, specifically lipopolysaccharides or LPS, are fragments of bacterial cell membranes. They’re a byproduct of gram-negative bacterial contamination during synthesis or handling. A vial can test at 99%+ HPLC purity and still carry meaningful endotoxin levels if manufacturing conditions weren’t properly controlled. The HPLC trace looks clean because LPS doesn’t absorb UV at the wavelengths used in standard peptide analysis. It’s essentially invisible to the test.

Why does this matter for research? Endotoxins are potent activators of innate immune signaling. In cell-based work, LPS contamination introduces inflammatory noise that can skew assays, activate NF-kB pathways, and confound any experiment where you’re trying to isolate the effect of the peptide itself. Inconsistent or non-replicating results in peptide research are sometimes blamed on the compounds, when the actual culprit is contaminants the standard purity test doesn’t pick up.

The test for endotoxins is called the LAL assay, short for Limulus Amebocyte Lysate. It uses a clotting agent derived from horseshoe crab blood that reacts specifically to endotoxins. It’s sensitive, well-established, and entirely separate from HPLC. It’s also something the vast majority of research peptide vendors don’t run.

They don’t run it because it costs money, takes time, and most buyers never ask for it. A vendor can publish a clean HPLC trace and a 99.2% purity number and never once address endotoxin levels. Most buyers look at the purity percentage and move on.

When I was building the testing standard for Anvil, the LAL endotoxin screen was non-negotiable. Every lot we bring into inventory goes through HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin screening before it ships. The COA for every lot reflects all three tests. Freedom Diagnostics in the USA runs the testing independently. We submit the samples. They report the results. We don’t control what the numbers come back as, and that’s the whole point.

The next time you’re evaluating a research compound supplier, ask one question: do your COAs include endotoxin screening results? The answer will tell you more about their testing program than the purity number alone.

View lot documentation at anvilcompounds.shop

Every COA includes LAL endotoxin results

Sold for laboratory research purposes only. Not for human or veterinary use.